Broughton Darren Chester
Transaction: 06/18/2026
OTHER
Change
0
Price
Not reported
Filing
06/30/2026
Type
OTHER
Cronos Group Inc.
CRON • Drug Manufacturers - Specialty & Generic
$3.26
— 0.00 (0.00%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.15B
Growth
—
Cash Flow
2/5
Trend
Volatile
Evidence
Positive revenue growth · 30.3%Positive free cash flow · 0Manageable debt level · 0Healthy liquidity · 19.59Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:13 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$3.26
Change0.00%
Market Cap$1.15B
52W Range2.14 - 3.43
Beta1.24
Dividend Yield0.00%
Gross Margin32.46%
Oper. Margin-1.51%
Profit Margin-4.89%
Debt/Eq0.00
Current Ratio19.59
Quick Ratio18.62
Price$3.26
Change0.00%
Market Cap$1.15B
52W Range2.14 - 3.43
Beta1.24
Dividend Yield0.00%
Gross Margin32.46%
Oper. Margin-1.51%
Profit Margin-4.89%
Debt/Eq0.00
Current Ratio19.59
Quick Ratio18.62
Target$3.15
Target Upside-3.37%
Target Median$2.90
Target Range2.30 - 4.50
Volume5.67M
Avg Volume1.16M
EPS Surprise0.00
Investment DNA
How strong this company looks for long-term investors
43
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Positive revenue growth · 30.3%Positive free cash flow · 0Manageable debt level · 0Healthy liquidity · 19.59Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 15 analyst votes · 2026-09-05
50/100
Neutral
Bullish
3
Hold
9
Bearish
3
Price Target
2026-08-07
Low
$2.30
Mean
$3.15
Median
$2.90
High
$4.50
Insider Transactions
Recent executive and insider activity
Kenost Jared Matthew
Transaction: 05/12/2026
SELL
Change
-3,701
Price
$2.75
Filing
05/14/2026
Type
SELL
Kenost Jared Matthew
Transaction: 05/12/2026
SELL
Change
-9,412
Price
Not reported
Filing
05/14/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Broughton Darren Chester | OTHER | 0 | Not reported | 06/18/2026 | 06/30/2026 |
| Kenost Jared Matthew | SELL | -3,701 | $2.75 | 05/12/2026 | 05/14/2026 |
| Kenost Jared Matthew | SELL | -9,412 | Not reported | 05/12/2026 | 05/14/2026 |
| Buggy Shannon | SELL | -20,622 | Not reported | 05/12/2026 | 05/14/2026 |
| Buggy Shannon | SELL | -9,179 | $2.75 | 05/12/2026 | 05/14/2026 |
| Wagner Adam | BUY | +10,367 | Not reported | 05/12/2026 | 05/14/2026 |
| Wagner Adam | SELL | -10,367 | Not reported | 05/12/2026 | 05/14/2026 |
| Doucet Terrence Gregory Joseph | SELL | -5,199 | $3.75 | 05/12/2026 | 05/14/2026 |
| Doucet Terrence Gregory Joseph | SELL | -10,597 | Not reported | 05/12/2026 | 05/14/2026 |
| Kenost Jared Matthew | SELL | -5,114 | Not reported | 05/10/2026 | 05/12/2026 |
| Kenost Jared Matthew | SELL | -2,896 | $2.54 | 05/10/2026 | 05/12/2026 |
| Wagner Adam | BUY | +10,063 | Not reported | 05/10/2026 | 05/12/2026 |
| Wagner Adam | SELL | -10,407 | Not reported | 05/10/2026 | 05/12/2026 |
| Weigensberg Arye | SELL | -3,118 | Not reported | 05/10/2026 | 05/12/2026 |
| Weigensberg Arye | BUY | +3,118 | Not reported | 05/10/2026 | 05/12/2026 |
| Shlimak Anna | SELL | -9,767 | $2.54 | 03/19/2026 | 03/20/2026 |
| Shlimak Anna | SELL | -28,429 | Not reported | 03/19/2026 | 03/20/2026 |
| Weigensberg Arye | BUY | +12,245 | Not reported | 03/16/2026 | 03/17/2026 |
| Buggy Shannon | SELL | -9,202 | $2.50 | 03/15/2026 | 03/17/2026 |
| Buggy Shannon | SELL | -20,938 | Not reported | 03/15/2026 | 03/17/2026 |